In the MIROCALS trial, Gilbert Bensimon and colleagues1 showed that low-dose interleukin-2 (IL-2) added to riluzole did not significantly reduce mortality in an unadjusted analysis of patients with ...
We thank Yutaka Shimazu for his insightful comments. We agree that our positive findings1–4 highlight the urgent need for further work on biomarkers of neuronal damage and immune mechanisms in ...
Bedding choice is a crucial factor in both cow comfort and udder health, and dairy farms in the Midwest are increasingly ...
Following an acute ischemic stroke, the risk of recurrent stroke is highest in the first 90 days. It is unclear whether this risk is altered by reperfusion therapy. In this meta-analysis, we aim to ...
Department of Cardiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China (X.L., P.Z., Z.L., H.Y., Y.L., J. Guo, N.Z.). Department of ...
1School of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. 2Department of Oncology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results